Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John B. Henneman III currently holds 12,555 shares of Aprea Therapeutics, Inc. (APRE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John B. Henneman III has been a net seller of APRE stock. They have purchased $719.1K and sold $23.9M worth of shares.
John B. Henneman III's most recent insider trade was on Jun 16, 2026, when they sold 12,555 shares at $0.00 per share.
John B. Henneman III serves as Executive at Aprea Therapeutics, Inc. (APRE). They have executed 258 insider transactions totaling $24.6M over their tenure at the company.
John B. Henneman III holds the position of Executive at Aprea Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
John B. Henneman III has shown a selling trading pattern, with $719.1K in total purchases and $23.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John B. Henneman III was on Aug 8, 2023, when they sold $858.5K worth of RCM shares. This transaction involved 50,000 shares at $17.17 per share.
John B. Henneman III currently owns 12,555 shares of Aprea Therapeutics, Inc. (APRE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John B. Henneman III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John B. Henneman III has 258 Form 4 filings on record as an insider at Aprea Therapeutics, Inc..
Set alerts for John B. Henneman III and 40,000+ other insiders.